20240326113011.png&width=400&height=400){kind=logo}
Prostate cancer is resistant to one of the most powerful chemotherapy medications — cisplatin. Now, researchers in ACS Central Science have developed the first therapy of its kind that disrupts prostate cancer cells’ metabolism and releases cisplatin into the weakened cells, causing them to die.
A freight train carrying industrial chemicals derailed near East Palestine, Ohio, in February 2023. Researchers have been assessing the local air quality. Now, in ACS’ Environmental Science & Technology Letters, they report that some gases, including acrolein, reached levels that could be hazardous.
Though antibiotics can treat leprosy, researchers are concerned about the increase in drug-resistant strains. Now, a team reporting in ACS Central Science has begun to understand the role certain immune receptors play in leprosy, which could lead to new types of treatments for this disease.
Inspired by squid skin, researchers in ACS Nano report a soft film that can regulate its transparency across a large range of wavelengths—visible, infrared and microwave—simultaneously. They demonstrated the material in smart windows and in health monitoring and temperature management applications.
Probiotics could be used as an effective treatment strategy for certain intestinal diseases, such as Crohn’s disease. Researchers reporting in ACS Central Science have developed a microgel delivery system for probiotics that keeps “good” bacteria safe while actively clearing out “bad” ones.
Journalists who register for the fall meeting of the American Chemical Society (ACS) will have access to about 12,000 presentations on topics including agriculture and food, energy and fuels, health and medicine, sustainability and more.
Chemical & Engineering News (C&EN), an independent news outlet of the American Chemical Society (ACS), has unveiled its annual “Talented 12” list. The list highlights early-career researchers in the chemical sciences who are fearlessly tackling difficult global problems.
Researchers reporting in ACS Central Science have now developed a system that directly targets and degrades the SARS-CoV-2 viral RNA genome, reducing infection in mice. The method could be adapted to fight off many viruses, as well as treat various diseases.
Roots of a traditional medicine plant called the orange climber can fluoresce an ethereal blue hue under ultraviolet (UV) light. And now, researchers in ACS Central Science have identified two coumarin molecules that could be responsible, one of the which could someday be used for medical imaging.
Some polymers can expand and contract — acting like artificial muscles — but only when stimulated by high voltages. Researchers in ACS Applied Materials & Interfaces report a series of thin, elastic films that respond to lower electrical charges, representing a step toward artificial muscles.
Researchers reporting in ACS Central Science have developed a new testing platform that encapsulates B cells — some of the most important components of the immune system — into miniature “organoids” to make vaccine screening quicker and greatly reduce the number of animals needed for testing.
Imagine getting the benefits of gastric bypass surgery without going under the knife. A new class of potential treatments has done that in lab animals, reducing weight dramatically and lowering blood glucose without side effects, scientists report. They will present their results at ACS Spring 2023.
Fermentation could bring a fruity taste to your morning cup of coffee. This new beverage has a raspberry-like taste and aroma, but what causes this has been a mystery. Today, scientists report six compounds that contribute to the unique experience. They will present their results at ACS Spring 2023.
Recordings of media briefings will be posted by 10 a.m. Eastern Time on each day. Watch recorded media briefings at: www.acs.org/ACSSpring2023briefings.
Scientists report using a single-atom-thick nanomaterial to build a device that can simultaneously detect the presence of the viruses that cause COVID-19 and the flu — at much lower levels and much more quickly than conventional tests for either. They will present their results at ACS Spring 2023.
Naloxone can reverse potentially fatal overdoses, but it’s less effective against powerful fentanyl. To develop alternatives, researchers are looking to a component of marijuana, CBD. They will present their results at ACS Spring 2023.
Colorful microplastics — less than 5 mm wide — drift along under the surface of most waterways. Now, a team reports a two-stage device made with steel tubes and pulsing sound waves to remove these potentially harmful particles from water samples. They will present their results at ACS Spring 2023.
Chemical engineers have extended the ancient art of origami to produce intricate shapes made of glass or other hard materials. Their method, which can be combined with 3D printing, could have applications ranging from sculpture to catalysis. They will present their results at ACS Spring 2023.
Needles are an uncomfortable but necessary aspect of vaccination. But today, scientists report steps toward an alternative, relatively painless method that can deliver biological materials to cells by “shooting” them in with air. They will present their results at ACS Spring 2023.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right